Biologics for Non-Cancer Dermatological Diseases: Analysis on China's Clinical Trial Registration Trend From 2016 to 2020
Background: In the past 5 years, China has quickly followed US's steps to approve the new drug application of biologics for dermatological diseases. There is an increasing interest in the current biologic landscape and further potentials in China. Our study aims to analyze features of clinical...
Saved in:
Main Authors: | Beibei Zhu (Author), Yi Liu (Author), Jing Li (Author), Qi Ni (Author), Zheng Yin (Author), Junli Zhu (Author), Ken Chen (Author), Xueyuan Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world prescription patterns for reproductive assistance patients in China: A trend analysis from 2016 to 2020
by: Jing Jin, et al.
Published: (2022) -
Newer signs in dermatology [2016-2020]
by: Anupam Das, et al.
Published: (2021) -
Trend and spatiotemporal distribution characteristics of malaria in mainland China - 2010 to 2017: an analysis on national registration data
by: Zhen-wei LI, et al.
Published: (2022) -
Trends and Patterns of Antibiotics Use in China's Urban Tertiary Hospitals, 2016-19
by: Yulei Zhu, et al.
Published: (2021) -
Analysis of Suspension of Clinical Trials for Drug Registration in China
by: Xian Su, et al.
Published: (2021)